Trial NCT03539601

View at ClinicalTrials.gov 
Org. Study IDs: C3291037
Secondary IDs: 2018-001043-31

Last trial update was posted on 2022-01-10

MeSH Interventions

Hydrocortisone Hydrocortisone-17-butyrate Pimecrolimus

MeSH Conditions

Dermatitis Dermatitis, Atopic Eczema

Other Conditions

Atopic Dermatitis

Stopping Reasons

This decision was made for business reasons only and is not related to any safety concerns regarding crisaborole.

Limitations And Caveats

Study was terminated early by sponsor. Decision was not due to safety/efficacy concerns, but was related to business, portfolio reprioritization. Sub-study planned as per Amendment 3 was not initiated, as sub study site setup didn't complete prior to study termination.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID